Medicine and Dentistry
Prostate Hypertrophy
100%
Lower Urinary Tract Symptom
43%
Overactive Bladder
41%
Urodynamics
26%
Chronic Prostatitis
26%
Chronic Pelvic Pain Syndrome
24%
Incision
22%
International Prostate Symptom Score
21%
Surgery
20%
Quality of Life
18%
Stress Incontinence
17%
Adverse Event
17%
Arm
15%
Bladder
13%
Obstruction
12%
Retreatment
11%
Prospective Study
11%
Systematic Review
11%
Interstitial Cystitis
11%
Nitinol
11%
Prostatectomy
11%
Bladder Outlet Obstruction
10%
Urologist
10%
Operation Duration
10%
Benign Prostatic Hyperplasia
9%
Randomized Controlled Trial
9%
Urology
9%
Prostate Specific Antigen
9%
Minimally Invasive Procedure
9%
Urinary System
8%
Incontinence
8%
Urine Flow Rate
8%
High Risk Population
7%
Anticoagulant
7%
Urination
7%
Comorbidity
6%
Urge Incontinence
6%
Urinary Retention
6%
Transrectal Ultrasonography
6%
Low Level Laser Therapy
6%
Uroflowmetry
6%
Voiding Dysfunction
6%
Diseases
6%
Pelvic Organ Prolapse
6%
Patient-Reported Outcome
6%
Residual Urine
5%
Cytokine
5%
Stone Formation
5%
Meta-Analysis
5%
Tissue Repair
5%
Keyphrases
Benign Prostatic Hyperplasia
31%
Overactive Bladder Symptom Score (OABSS)
22%
Chronic Prostatitis
20%
Water Vapor Thermal Therapy
16%
Chronic Pelvic Pain Syndrome
16%
Lower Urinary Tract Symptoms
15%
Urodynamics
9%
Painful Bladder Syndrome/interstitial Cystitis
7%
Minimally Invasive
7%
Prostate
6%
Voiding Dysfunction
6%
Bladder Outlet
6%
Functional Magnetic Resonance Imaging
5%
Genitourinary Syndrome of Menopause
5%
Vaginal Laser
5%
Chronic Bacterial Prostatitis
5%
Lithium Triborate
5%
Urgency Urinary Incontinence
5%
Bovine Bone Graft
5%
Neural Changes
5%
Supraspinal
5%
Photoselective Vaporization of the Prostate
5%
W-system
5%
GreenLight XPS
5%
Alfuzosin
5%
Treatment Strategy
5%
Tadalafil
5%
Landmark Trials
5%
Minimally Invasive Treatment
5%
Laser Photoselective Vaporization
5%
ITIND
5%
Nonbacterial
5%
Pseudodyssynergia
5%
Perineal Pain
5%
Voiding Disorders
5%
Anti-inflammatory Peptides
5%
Prostatic Urethral Lift
5%
Convective Water Vapour Energy
5%
Energy Therapies
5%
MRI Study
5%
Benign Prostatic Enlargement
5%
Holmium Laser Enucleation of the Prostate (HoLEP)
5%
Urodynamic Findings
5%
Pelvic Floor
5%
Radio Frequency
5%
Pelvic Pain Syndrome
5%
Adrenal Oncocytoma
5%
Adrenocortical Oncocytoma
5%
Transurethral Needle Ablation of the Prostate
5%
Transurethral Microwave Thermotherapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Hypertrophy
59%
Lower Urinary Tract Symptom
31%
Overactive Bladder
22%
Bladder Obstruction
11%
Erectile Dysfunction
6%
Urge Incontinence
6%
Azoospermia
5%
Nitinol
5%
Alfuzosin
5%
Tadalafil
5%
Arteriovenous Malformation
5%
Prostate Cancer
5%
Cholinergic Receptor Blocking Agent
5%
Experimental Cystitis
5%
Norleucine
5%
Randomized Controlled Trial
5%
Anticoagulant Agent
5%
Prostate Specific Antigen
5%
Antigen
5%
Sabal
5%
